Category: Approval/Launch Region: North America · United States Company: Angion Biomedica Corporation

Angion Biomedica gets US FDA clearance to initiate phase 1b study of ANG-3070 in patients with IPF

By, Admin 1 min read
Share
Angion Biomedica gets US FDA clearance to initiate phase 1b study of ANG-3070 in patients with IPF
Angion Biomedica Corp., a biopharmaceutical company, announced US Food and Drug Administration

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!